NEW ENGLAND JOURNAL OF MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2024-05-02 ms1000000394057031

偏重的研究方向：临床研究;随机对照研究;临床
经验分享：刚投了一篇image，当天with the editor，目前5天

426 12

展开12条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2019-07-09 太子-大医精诚

4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况

467 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2022-04-27 大學朝陽

审稿速度:2.0 | 投稿命中率:25.0
偏重的研究方向：神经病学;神经介入
经验分享：Images in Clinical Medicine收录

2258 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2024-07-03 杨洋阳羊来自北京

投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢

0 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2024-06-20 侠胆医心来自伊利诺伊

审稿速度:2.0 | 投稿命中率:5.0
偏重的研究方向：综合期刊;医学综合;心血管
经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。

321 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2021-02-07 12103978m50暂无昵称

投了一篇letter不知道with edtor要多少天

1 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2024-01-23 ms6000000966266302 来自重庆

23.12.17投稿 picture，with the editor 一月有余

429 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2023-11-09 ms2000001241893328 来自山东省

偏重的研究方向：临床研究
经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果

485 0

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2016-02-27 zhihenghuang

投了1篇病例报道，现在Assigned to an Editor，估计希望不大。

1230 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2201497, encodeId=0720220149e8a, content=偏重的研究方向：临床研究;随机对照研究;临床 经验分享：刚投了一篇image，当天with the editor，目前5天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=426, replyNumber=12, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4528231473, createdName=ms1000000394057031, createdTime=Thu May 02 20:07:39 CST 2024, time=2024-05-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=573504, encodeId=f4315e3504f9, content=4月24号投的image,目前已经两个半月了，还是with the editor，求大神指导一下目前状态是什么情况, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=467, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/07/12/b1d88d10acbe92d48c510912f76a780c.jpg, createdBy=a54d2142874, createdName=太子-大医精诚 , createdTime=Tue Jul 09 00:00:00 CST 2019, time=2019-07-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1215148, encodeId=20091215148c4, content=审稿速度:2.0 | 投稿命中率:25.0 偏重的研究方向：神经病学;神经介入 经验分享：Images in Clinical Medicine收录, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=2258, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTK3Ce64FXVn7Sv0ib3vEEa6kfmgibTiaz4gNVGzddmZsFI5PSI4JuFiac07HncAZQsIvI1xp88C97jFIw/132, createdBy=e72b2408943, createdName=大學朝陽, createdTime=Wed Apr 27 22:14:03 CST 2022, time=2022-04-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2212920, encodeId=6229221292072, content=投的letter，快一个月了，还是没信，大家都是好久分配编辑的呢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220320/fe2a6193a9dd4638b61962dd57588e63/cf4a4a34a69c4bd3aa6b026546940e7d.jpg, createdBy=f3e95470708, createdName=杨洋阳羊, createdTime=Wed Jul 03 09:38:12 CST 2024, time=2024-07-03, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2210796, encodeId=bda72210e968f, content=审稿速度:2.0 | 投稿命中率:5.0 偏重的研究方向：综合期刊;医学综合;心血管 经验分享：NEJM在2023年度影响因子96.2，LANCET为98.4， BMJ为93.6，JAMA为63.1，表面看除JAMA外，三个名刊影响因子是差不多的，但是主要受前两年新冠相关文章的影响。到明年，BMJ和Lancet影响因子应该会较大幅度下降，但是JAMA和NEJM仍然能保持。NEJM仍然是行业老大，这个地位不会改变的。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=321, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/Random/55971dc507c93968175ce7cc1e177b372a83869f.jpg, createdBy=f63e4754896, createdName=侠胆医心, createdTime=Thu Jun 20 13:48:55 CST 2024, time=2024-06-20, status=1, ipAttribution=伊利诺伊), GetPortalCommentsPageByObjectIdResponse(id=923533, encodeId=449592353316, content=投了一篇letter不知道with edtor要多少天, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd8d2221982, createdName=12103978m50暂无昵称, createdTime=Sun Feb 07 20:48:35 CST 2021, time=2021-02-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2183346, encodeId=65c9218334693, content=23.12.17投稿 picture，with the editor 一月有余, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=429, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b9f5529296, createdName=ms6000000966266302, createdTime=Tue Jan 23 03:56:44 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2167508, encodeId=a8c2216e5081e, content=偏重的研究方向：临床研究 经验分享：2023-11-7投了一篇针对某篇论文的letter, 希望能有好结果, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=485, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=c6bb5724422, createdName=ms2000001241893328, createdTime=Thu Nov 09 07:36:14 CST 2023, time=2023-11-09, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=519664, encodeId=68e35196644d, content=投了1篇病例报道，现在Assigned to an Editor，估计希望不大。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1230, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=eb9b27436, createdName=zhihenghuang, createdTime=Sat Feb 27 10:15:00 CST 2016, time=2016-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2148071, encodeId=21bd21480e1d6, content=审稿速度:3.0 | 投稿命中率:5.0 偏重的研究方向：随机对照研究 经验分享：规范的多中心大样本的文章临床文章相对容易点被接收, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=643, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9f0d8457117, createdName=ms6000000447690824, createdTime=Fri Jul 14 20:16:03 CST 2023, time=2023-07-14, status=1, ipAttribution=广东省)]

2023-07-14 ms6000000447690824 来自广东省

审稿速度:3.0 | 投稿命中率:5.0
偏重的研究方向：随机对照研究
经验分享：规范的多中心大样本的文章临床文章相对容易点被接收

643 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务